SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., a developer of pioneering technologies to empower science, today introduced Trinity™ - an innovative solution that simplifies target capture sequencing by eliminating or moving traditionally time-consuming steps to the AVITI™ System and providing customers with the option to dramatically reduce hybridization time, without sacrificing cost or quality..

圣地亚哥--（商业新闻短讯）--Element Biosciences，Inc.，一家致力于增强科学能力的开创性技术的开发公司，今天推出了Trinity™，这是一种创新的解决方案，通过消除或将传统上耗时的步骤移到AVITI™系统来简化目标捕获测序，并为客户提供了在不牺牲成本或质量的情况下大幅缩短杂交时间的选择。。

Launching today at BEYOND, Element’s inaugural annual virtual event, the first Trinity product is an exome target capture solution that allows researchers to concentrate sequencing on the most relevant genomic regions, reducing both time and costs compared to whole genome sequencing (WGS). By simplifying the operational complexity of exome sequencing, Trinity makes advanced genomic research faster and more accessible than ever, initially for exomes but rapidly expanding to support custom panels of any size across a wide array of applications, including comprehensive cancer panels, respiratory panels, and MRD..

第一款Trinity产品今天在Element的首届年度虚拟活动BEYOND上推出，它是一种外显子组靶标捕获解决方案，允许研究人员将测序集中在最相关的基因组区域，与全基因组测序（WGS）相比，既减少了时间又减少了成本。通过简化外显子组测序的操作复杂性，Trinity使先进的基因组研究比以往任何时候都更快，更容易获得，最初用于外显子组，但迅速扩展以支持各种应用中任何大小的定制面板，包括综合癌症面板，呼吸面板和MRD。。

Trinity is the first major advancement in exome target capture sequencing in over two decades, streamlining a traditionally complex, hands-on process to capture and sequence key regions of DNA. Trinity uses a new flow cell and paired reagents to complete the capture, wash, and sequencing steps on the AVITI™ System, eliminating the need for specialized equipment and saving up to five hours of manual work.

Trinity使用一个新的流动池和成对的试剂来完成AVITI™系统上的捕获，洗涤和测序步骤，无需专门的设备，节省了多达五个小时的手动工作。

With the addition of a 1-hour fast hybridization option, Trinity enables same-day sequencing results, making it ideal for time-sensitive studies..

通过添加1小时快速杂交选项，Trinity可以实现当天的测序结果，使其成为时间敏感研究的理想选择。

'Trinity will make hybrid selection sequencing no more complex than generating a sequencing library and starting a sequencer,' said Shawn Levy, Chief Scientific Officer and SVP of Applications. “It radically changes a long-standing workflow in targeted sequencing.'

首席科学官兼应用高级副总裁肖恩·利维（ShawnLevy）说：“Trinity将使杂交选择测序不比生成测序库和启动测序仪更复杂。”“它彻底改变了目标测序的长期工作流程。”

Trinity™ is available for order beginning today, October 16, 2024, and integrates seamlessly with Element’s AVITI™ and AVITI24™ systems. Element Biosciences has partnered with Integrated DNA Technologies (IDT) and Twist Bioscience to provide the necessary exome-targeting tools for the Trinity workflow..

Trinity™于2024年10月16日开始订购，并与Element的AVITI™和AVITI24™系统无缝集成。Element Biosciences与Integrated DNA Technologies（IDT）和Twist Bioscience合作，为Trinity工作流程提供必要的外显子组靶向工具。

'Trinity saves researchers valuable time and lets them concentrate on the most critical aspects of their work,' said Molly He, CEO and co-founder of Element Biosciences. 'With Trinity, we continue to push the boundaries of innovation, providing a comprehensive suite of genomic tools in a unified platform.'.

Element Biosciences首席执行官兼联合创始人莫莉·何（MollyHe）说：“Trinity为研究人员节省了宝贵的时间，让他们专注于工作中最关键的方面。”凭借Trinity，我们继续推动创新的边界，在统一平台上提供一套全面的基因组工具。”

'This partnership with Element Biosciences exemplifies IDT's high-performing chemistry and exome design, and commitment to empowering researchers by delivering cutting-edge tools that enhance efficiency,” says Linda De Jesus, Vice President and General Manager, Global Commercial Operations at IDT. “By integrating IDT's exome-targeting technologies into the Trinity workflow, we are enabling our customers to achieve more actionable genomic insights, accelerating their research timelines and advancing scientific discovery.'.

“与Element Biosciences的合作体现了IDT的高性能化学和外显子组设计，以及通过提供提高效率的尖端工具来赋予研究人员权力的承诺，”IDT全球商业运营副总裁兼总经理Linda De Jesus说。“通过将IDT的外显子组定位技术整合到Trinity工作流程中，我们使我们的客户能够获得更多可行的基因组见解，加快他们的研究时间表并推进科学发现。”

'In our continued commitment to advance sequencing solutions across platforms, Twist is pleased to continue our collaboration with Element and the release of Trinity-compatible workflows,' said Emily M. Leproust, Ph.D., CEO and co-founder of Twist. 'Incorporating the evolution of our Fast Hyb workflows to reduce the time from sample to sequencer significantly enables applications which demand rapid turnaround without compromising data quality, pushing the boundaries of sequencing innovation and opening doors to new possibilities.'.

Twist首席执行官兼联合创始人艾米丽·莱普洛斯（EmilyM.Leproust）博士说：“在我们继续致力于跨平台推进测序解决方案的过程中，Twist很高兴继续与Element合作，并发布与Trinity兼容的工作流程。”结合我们快速Hyb工作流程的演变，以减少从样本到测序仪的时间，可以显着实现需要快速周转而不影响数据质量的应用，推动测序创新的界限，并为新的可能性打开大门。”

About Element Biosciences, Inc.

关于Element Biosciences，Inc

Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multi-omics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries.

Element Biosciences是一家开创性的生命科学公司，将先进生物工具的使用民主化，推动有影响力的发现造福人类。我们专注于为研究市场开发破坏性DNA测序和多组学技术。通过创新生物测定系统的每个基本元素，element为客户提供了负担得起的高质量数据和改进的用户体验，这反过来将加速科学发现。